EP1578945A3 - Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren - Google Patents
Cct6s als modifikatoren des rb-wegssowie verwendungsverfahrenInfo
- Publication number
- EP1578945A3 EP1578945A3 EP03789986.1A EP03789986A EP1578945A3 EP 1578945 A3 EP1578945 A3 EP 1578945A3 EP 03789986 A EP03789986 A EP 03789986A EP 1578945 A3 EP1578945 A3 EP 1578945A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- cct6s
- modifiers
- pathway
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003607 modifier Substances 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42887202P | 2002-11-25 | 2002-11-25 | |
US428872P | 2002-11-25 | ||
PCT/US2003/037548 WO2004048541A2 (en) | 2002-11-25 | 2003-11-24 | Cct6s as modifiers of the rb pathway and methods of use |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1578945A3 true EP1578945A3 (de) | 2005-08-18 |
EP1578945A2 EP1578945A2 (de) | 2005-09-28 |
EP1578945A4 EP1578945A4 (de) | 2006-09-27 |
Family
ID=32393472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03789986A Withdrawn EP1578945A4 (de) | 2002-11-25 | 2003-11-24 | Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1578945A4 (de) |
JP (1) | JP4646631B2 (de) |
AU (2) | AU2003294499A1 (de) |
CA (1) | CA2506686A1 (de) |
WO (2) | WO2004048541A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008133904A1 (en) | 2007-04-23 | 2008-11-06 | Stowers Institute For Medical Research | Methods and compositions for stem cell self-renewal |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071715A (en) * | 1993-08-12 | 2000-06-06 | Board Of Regents, The University Of Texas System | Nucleic acids encoding novel proteins which bind to retinoblastoma protein |
GB9608937D0 (en) * | 1996-04-29 | 1996-07-03 | Cancer Res Campaign Tech | Screening methods for therapeutics and peptides used in the screen |
EP1054969A2 (de) * | 1998-02-12 | 2000-11-29 | Curagen Corporation | Retinoblastomprotein komplexe und proteine die mit dem retinoblastomprotein wechsel wirken |
-
2003
- 2003-11-24 AU AU2003294499A patent/AU2003294499A1/en not_active Abandoned
- 2003-11-24 JP JP2004555682A patent/JP4646631B2/ja not_active Expired - Fee Related
- 2003-11-24 WO PCT/US2003/037548 patent/WO2004048541A2/en active Application Filing
- 2003-11-24 EP EP03789986A patent/EP1578945A4/de not_active Withdrawn
- 2003-11-24 WO PCT/US2003/037538 patent/WO2004048536A2/en not_active Application Discontinuation
- 2003-11-24 CA CA002506686A patent/CA2506686A1/en not_active Abandoned
- 2003-11-24 AU AU2003294501A patent/AU2003294501B2/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003224638A1 (en) | PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003248879A1 (en) | RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003272400A1 (en) | Syts as modifiers of the p21 pathway and methods of use | |
AU2003251799A1 (en) | Mchks as modifiers of the chk1 pathway and methods of use | |
AU2003274911A1 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
AU2003295881A1 (en) | Lamps as modifiers of the p53 pathway and methods of use | |
AU2003265263A1 (en) | ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
EP1578945A3 (de) | Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren | |
AU2003294499A1 (en) | Rhebs as modifiers of the rb pathway and methods of use | |
AU2003303094A1 (en) | MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003251826A1 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
AU2003258095A1 (en) | MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
AU2003299990A1 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003217851A1 (en) | MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE | |
AU2003213693A1 (en) | MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE | |
AU2003213665A1 (en) | Lgals as modifiers of the chk pathway and methods of use | |
AU2002361654A1 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003278811A1 (en) | LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003248876A1 (en) | MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003295928A1 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003213662A1 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
AU2003223208A1 (en) | MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
AU2003215004A1 (en) | Msrebps as modifiers of the srebp pathway and methods of use | |
EP1587910A4 (de) | Facls als modifikatoren des rb-wegs undverwendungsverfahren | |
EP1633852A4 (de) | Sppls als modifikatoren des p53-wegs und verwendungsverfahren |